Upgrade to SI Premium - Free Trial

Mizuhoon Harmony Biosciences (HRMY): 'we recommend being opportunistic on yesterday's share weakness'

October 23, 2026 7:11 AM
Mizuho analyst Graig Suvannavejh reiterated an Outperform rating and $51.00 price target on Harmony Biosciences Holdings Inc. (NASDAQ: HRMY)The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Comments